BIOCEUTICAL PATENT PORTFOLIO FOR LUXEMBOURG BIOCEUTICAL INNOVATIONS
Ce jeu de données a été publié le 14 mai 2020 et mis à jour le 14 mai 2020 à l'initiative et sous la responsabilité de Erdal Can Alkoclar
WE HEREBY PUBLISH OUR BIOCEUTICAL PATENT PORTFOLIO THAT MAY PROVIDE EFFICIENT CURATIVE & PREVENTIVE MEANS FOR THE MOST SEEN MEDICAL AILMENTS IN LUXEMBOURG. OUR FORMULATIONS PORTFOLIO LISTED IN THIS DATASET INCLUDES BCL-2 EXPRESSION INHIBITORS, CYCLIN B1 & D2 INHIBITORS, Hıf-10 SUPPRESSIVE AGENTS, TNF-A & NF-KAPPA B COX-2 INTERLEUKIN-6 SUPPRESSIVE AND IMMUNOMODULATIVE AGENTS FOR AUTOIMMUNE DISEASES, FMO3 SUPPRESSIVE ANALGESIC AGENTS, THYROGENIC & THYROMODULATORY AGENTS, RNA POLYMERASE & DNA POLYMERASE & VIRAL DNA GYRASE SUPPRESSIVE ANTIVIRAL AGENTS, TOPOISOMERASE I & II, RIBONUCLEOTIDE REDUCTASE SUPPRESSIVE ANTIBACTERIAL AGENTS, GLUT4 TRANSLOCATIVE ANTIDIABETIC AGENTS AND MANY OTHER INNOVATIVE FORMULATIONS WITH NOVEL MECHANISMS OF ACTION.
WE HEREBY DISCLOSE OUR INVENTIONS FOR THE GREAT PEOPLE OF LUXEMBOURG IN ORDER TO PROVIDE AND EFFICIENT CONTRIBUTION TO THEIR COLLECTIVE HEALTH, AND FOR ALL.
BEST REGARDS
ERDAL CAN ALKOCLAR & METEHAN YESIL
Ressources
A COMPOSITION PROMOTING HEPATIC AND INTESTINAL TISSUE RENEWAL
A COMPOSITION FOR PROMOTING TISSUE RENEWAL
TR201305306 WIPO NOVELTY REPORT
TR201305054 WIPO PATENT NOVELTY REPORT
TR201304493 WIPO NOVELTY REPORT
TR201304603 WIPO PATENT NOVELTY REPORT
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CANCER CHARACTER BY SUPPRESSING THE BCL-2 EXPRESSION
A COMPOSITION COMPRISING PICRORETINE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF HIGH CHOLESTEROL
A COMPOSITION COMPRISING SYNTHETIC PROTOBIOSIDE DERIVATIVES THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER
A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE HYPOLIPIDEMIC CHARACTER
A COMPOSITION COMPRISING ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING dnaB HELICASE
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HIF PROLYL HYDROXYLASE AND THE USE OF THIS COMPOSITION AS AN ADJUVANT CANCER THERAPY
AN ANTIVIRAL COMPOSITION
A NEUROTROPHIC COMPOSITION
A COMPOSITION COMPRISING LIPOLYTIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOCYTE CHEMOATTRACTANT PROTEIN-1
A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PI3-KINASE ALPHA
A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK
A COMPOSITION COMPRISING ANTI-CARCINOGENIC GIPENOLIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING ERK
A COMPOSITION COMPRISING SORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING H3K27 METHYLATION
A COMPOSITION COMPRISING ANTI-CARCINOGENIC PROTOSPINOL DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HYPOXIA-INDUCIBLE FACTOR (HIF) 1-ALPHA
A COMPOSITION COMPRISING ANABOLIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF PROMOTING THE AGRIN EXPRESSION
A COMPOSITION COMPRISING TRICYCLOPENTAONE DERIVATIVES THAT SUPPORT THE INCREASE OF THE MUSCLE STRENGTH BY MEANS OF AN INCREASE IN THE SENSITIVITY OF MUSCLE-SPECIFIC KINASE RECEPTOR
A COMPOSITION CONTAINING PICRORETOSIDE DERIVATIVES THAT EXHIBIT PRO-DOPAMINERGIC CHARACTER FOR INCREASING THE SENSITIVITY OF DOPAMINE 5 RECEPTOR
A COMPOSITION CONTAINING PICRORETINE DERIVATIVES THAT TRIGGER THE ENDOGENOUS PHENETHYLAMINE PRODUCTION AND THE USE THEREOF FOR NOOTROPIC PURPOSE
A COMPOSITION CONTAINING PYRANOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF TRIGGERING AN INCREASE IN THE ACTIVITY OF AROMATIC AMINO ACID DECARBOXYLASE AND THE USE OF THIS COMPOSITION FOR THE TREATMENT OF DOPAMINERGIC DEFECTS
A COMPOSITION CONTAINING PSEUDOBIOCIDE DERIVATIVES THAT EXHIBIT GABAA RECEPTOR ANTAGONISTIC CHARACTER AND THE USE THEREOF FOR MYOTROPIC PURPOSE
A COMPOSITION COMPRISING MYOTROPIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING MONOAMINE OXIDASE B
A COMPOSITION COMPRISING BIOFLAVONOL GLYCOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING OSTEONECROSIS
A COMPOSITION CONTAINING SYNTHETIC COMPONENTS FORMED FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE
A COMPOSITION COMPRISING SYNTHETIC PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING 3-PHOSPHOSHIKIMATE 1-CARBOXYVINYL TRANSFERASE
A COMPOSITION COMPRISING NOVEL SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PEPTIDOGLYCAN HYDROLASE
A COMPOSITION COMPRISING SYNTHETIC ANTI-BACTERIAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING EPOXIDE HYDROLASE
A COMPOSITION COMPRISING OXYDERRICIN DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA LIGASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF BACTERIAL INFECTIONS
A COMPOSITION COMPRISING CHALCOCITE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING BACTERIAL TERPENE SYNTHASE
A COMPOSITION COMPRISING NOVEL İZOTERİSİN DERIVATIVES THAT EXHIBIT ANTI-BACTERIAL CHARACTERISTIC
A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION WITH THE CHARACTERISTIC OF SUPPRESSING NF-KAPPA B
A COMPOSITION COMPRISING ANTI-BACTERIAL PSEUDO-PROTOBIOCIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING CYTOCHROME C PEROXIDASE
A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA LIGASE
A COMPOSITION COMPRISING SYMPLORACEMOSINE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE AND THE USE OF THIS COMPOSITION AS ANTI-VIRAL TREATMENT
A COMPOSITION COMPRISING SYNTHETIC COMPONENTS THAT EXHIBIT ANTI-VIRAL ACTION
A COMPOSITION COMPRISING SYNTHETIC PICRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA GYRASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS
A COMPOSITION COMPRISING PICRORETOSIDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING HEMAGGLUTININ ESTERASE AND THE USE OF THIS COMPOSITION IN THE TREATMENT OF VIRAL INFECTIONS
A COMPOSITION COMPRISING ANTI-VIRAL METHOXYSORININ DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING RIBONUCLEOTIDE REDUCTASE
A COMPOSITION COMPRISING SYNTHETIC METHYLPROTOBIOCIDE DERIVATIVES THAT EXHIBIT ANTI-VIRAL ACTION
A COMPOSITION COMPRISING SYMPLORACEMOSİDE ANALOGUES THAT EXHIBIT ANTI-VIRAL ACTION WITH THE CHARACTERISTIC OF SUPPRESSING RNA HELICASE
A COMPOSITION COMPRISING SYNTHETIC PİCRORETOSİDE DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING DNA TOPOISOMERASE
A COMPOSITION COMPRISING ANTI-VIRAL COMPONENTS THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING NEUROAMINIDASE
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION WITH THE CHARACTERISTIC OF SUPPRESSING THE GL1 EXPRESSION
A COMPOSITION COMPRISING ANTI-CARCINOGENIC SİMPLORASEMOSİT DERIVATIVES THAT EXHIBIT THE CHARACTERISTIC OF SUPPRESSING PHOSPHATIDYL 3-KINASE EXPRESSION
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-CARCINOGENIC ACTION FORMED FOR SUPPRESSING H3K27 METHYLTRANSFERASE
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-NOCICEPTIVE ACTION FORMED FOR SUPPRESSING PGE2 EXPRESSION
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-INFLAMMATORY ACTION FORMED FOR SUPPRESSING TYROSINE KINASE
A COMPOSITION COMPRISING COMPONENTS THAT EXHIBIT ANTI-OBESITY ACTION FORMED FOR SUPPRESSING 5-LIPOOXYGENASE
A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FOR SUPPRESSING DNA GYRASE
A COMPOSITION COMPRISING THE ANTIVIRAL COMPONENTS FOR SUPPRESSING RIBONUCLEOTIDE REDUCTASE
A COMPOSITION COMPRISING THE ANTI-VIRAL COMPONENTS FORMED FOR SUPPRESSING DNA POLYMERASE
A FORMULATION COMPRISING OF SYMPLOSOSIDE DERIVATIVES THAT ARE CHARACTERIZED BY TRIGGERING ENDOGENOUS PROTEIN KINASE PKR AND RNASE L EXPRESION
A FORMULATION COMPRISING OF SYMPLOSOSIDE DERIVATIVES INTENDED TO SUPPRESS NUCLEOSIDE REVERSE TRANSCRIPTASE
A FORMULATION INTENDED FOR TREATMENT OF TYPE 1 DIABETES
A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING NESTIN EXPRESSION
AN ANTI-CARCINOGENIC ADJUVANT FORMULATION THAT FUNCTIONS BY SUPPRESSING G1/S PHASE SPECIFIC PROTEIN, CYCLINE D1 AND ANTI-APOPTOTIC BCL-XL PROTEIN EXPRESSION
A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING TYROSİNASE, (TRP-1) AND MITF PROTEINS’ EXPRESSION AND FUNCTION
A FORMULATION DISPLAYING ANTI-MITOTIC EFFECT BY SUPPPRESSING CDK-1 CDK-2 AND CYCLINE B1 EXPRESSION
A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT WITH HIF-1 ALPHA SUPPRESSION
A FORMULATION DISPLAYING AN ANTI-CARCINOGENIC EFFECT BY SUPPRESSING VCAM-1 EXPRESSION WHICH IS TRIGGERED BY TNF-A
A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY AURORA A KINASE PHOSPHORILATON SUPPRESSION
A FORMULATION INTENDED TO SUPPRESS THE CDC25 PHOSPHATASE AND CDC/2 CYCLINE B KINASE ACTIVITIES
A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT WITH ITS NADH OXIDASE SUPPRESSION CAPABILITY
A FORMULATION INTENDED TO SUPPRESS MMP-9 SECRETION AND RELEASE
A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT BY ITS NF-KAPPA B SUPPRESSION CAPABILITY
A FORMULATION DISPLAYING ANTI-CARCINOGENIC EFFECT BY SUPPRESSING GLYCOPROTEIN CD44 AND CXC CHEMOKINE RECEPTOR-4 (CXCR4) EXRESSIONS
A FORMULATION INTENDED TO DISPLAY AN ANTI-CARCINOGENIC EFFECT VIA MEK SUPPRESSIVE FEATURES
A FORMULATION INTENDED TO HAVE AN ANTI-CARCINOGENIC EFFECT BY İTS BCL2 SUPPRESSİNG FUNCTİON
A FORMULATION INTENDED TO HAVE ANTI-CARCINOGENIC EFFECT BY STIMULATING BAX EXPRESSION
A FORMULATION INTENDED TO SLOW DOWN THE PROGRESS OF CANCER
FORMULATION INTENDED FOR TREATMENT OF HYPO-ADRENALISM
A FORMULATION INTENDED FOR TREATMENT OF CHOLERA
A FORMULATION INTENDED FOR ADJUVANT TREATMENT OF AIDS
A FORMULATION INTENDED FOR TREATMENT OF MALARIA
A FORMULATION DEVELOPED FOR TREATMENT OF SUBSTANCE ADDICTION
AN ADJUVANT FORMULATION PREPARED FOR SYMPTOMATIC TREATMENT OF SCHIZOPHRENIA
AN ADJUVANT COMPOSITION INTENDED FOR TREATMENT OF LEUKEMIA
A FORMULATION INTENDED FOR TREATMENT OF RENAL FAILURE
A FORMULATION INTENDED FOR TREATMENT OF INTESTINAL MALABSORPTION
A FORMULATION INTENDED FOR TREATMENT OF CROHN’S DISEASE
A COMPOSITION FOR THE TREATMENT OF ATTENTION AND CONCENTRATION DEFICIT DISORDERS
A COMPOSITION FOR TREATING ANXIETY AND DEPRESSION
A FORMULATION INTENDED FOR THE TREATMENT OF PARKINSON’S DISEASE
A COMPOSITION FOR TREATING THE MUSCLE WEAKNESS AND THE LOSS OF MUSCLE MASS FOLLOWING CHRONIC STROKE AND COMA
A FORMULATION INTENDED FOR TREATMENT OF CHRONIC PAIN
A COMPOSITION FOR ACCELERATING THE WOUND HEALING IN DIABETIC PATIENTS
A COMPOSITION FOR INCREASING THE PRODUCTION AND EXPRESSION OF NERVE GROWTH FACTOR
A COMPOSITION FOR THE TREATMENT OF ALLERGIC REACTIONS
A COMPOSITION PROMOTING DENTINE FORMATION
A COMPOSITION FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME
A HYPOTHERMIC, HYPOTENSIVE AND HYPOLIPIDEMIC COMPOSITION
A COMPOSITION FOR THE TREATMENT OF OBESITY
A SOMATOTROPIC AND PRO-THYROGENIC COMPOSITION FORMED FOR TREATING GROWTH/DEVELOPMENT/DWARFISM SYNDROMES
A COMPOSITION FOR INCREASING ATHLETIC PERFORMANCE
A COMPOSITION FOR SUPPORTING THE HEALING PROCESS OF THE WOUNDS AND GENERAL TISSUE DAMAGES
A COMPOSITION FOR THE TREATMENT OF HYPOTHYROIDISM
A COMPOSITION FOR THE TREATMENT OF IMMUNODEFICIENCY
A COMPOSITION FOR TREATING HEART ASTHENIA
A COMPOSITION FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS
A COMPOSITION FOR THE TREATMENT OF SPERM PRODUCTION DEFECTS 1.1
A COMPOSITION FOR THE TREATMENT OF MYASTHENIA
A COMPOSITION FOR THE TREATMENT OF ASTHENIA
A COMPOSITION FOR USE IN THE TREATMENT OF SUBSTANCE DEPENDENCE
A COMPOSITION FOR INCREASING THE SPEED OF WOUND HEALING
A COMPOSITION FOR REDUCING INSULIN DEPENDENCE IN THE TYPE 1 DIABETES DISEASE
A COMPOSITION FOR THE TREATMENT OF NEUROENDOCRINAL DAMAGE CAUSED BY AUTOIMMUNE DISEASES
A COMPOSITION FOR THE TREATMENT OF SARCOPENIA
A COMPOSITION FOR THE TREATMENT OF AUTOIMMUNE DISEASES
A COMPOSITION FOR THE TREATMENT OF TURNER SYNDROME
A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF MS AND ALS DISEASES
A COMPOSITION FOR THE TREATMENT OF NECROSIS
A COMPOSITION FOR ANTIVIRAL USE
A COMPOSITION FOR THE TREATMENT OF MALIGNANT TUMORS
A COMPOSITION FOR THE TREATMENT OF ACHONDROPLASIA AND GENERAL DEVELOPMENT DISORDERS
A COMPOSITION FOR THE SYMPTOMATIC TREATMENT OF ARTHROSIS
A PROTOPANAXTRIOL COMPOSITION FOR THE TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA
A COMPOSITION FOR THE TREATMENT OF ARTHROPATHY DERIVATIVES
A COMPOSITION FOR USE IN THE TREATMENT OF ALCOHOL ADDICTION
USE OF 3,7-BIS(2-HYDROXYETHYL)-3,5-TRIHYDROXY-2-(4-EPOXYPHENYL)-8-(3-METHYL-2-BUTEN-1-YL)-4H-1-BENZOPYREN-4-ONE AND DERIVATIVES THEREOF FOR THE TREATMENT OF OSTEOPOROSIS
A COMPOSITION FOR THE TREATMENT OF PARKINSON’S DISEASE
A COMPOSITION FOR THE TREATMENT OF ANDROPAUSE
A COMPOSITION PREPARED FOR THE TREATMENT OF ALS
A COMPOSITION FOR TREATMENT OF DEPRESSION
A COMPOSITION FOR PREVENTING GERIATRIC CACHEXIA
A COMPOSITION FOR THE TREATMENT OF TRIGEMINAL NEURALGIA
A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS
A COMPOSITION PREPARED FOR THE TREATMENT OF OLFACTORY NERVE NEUROPATHY
A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY
A COMPOSITION FOR THE TREATMENT OF OPTIC NERVE NEUROPATHY 1.1
A COMPOSITION FOR PREVENTING AND TREATING OBESITY
A NOOTROPIC COMPOSITION
A COMPOSITION FOR THE TREATMENT OF B CELL DEFICIENCY
A COMPOSITION FOR TREATING SPINAL CORD INJURY
A COMPOSITION ABOUT THE TREATMENT OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS
A HYPOTHERMIC COMPOSITION
2- USING [(4-FLUOROETHYL)SULFONYL]DIHYDROPYRROLO[5,6-A]PYRAZINE-4(2H)-DIONE AND ITS ANALOGUES FOR DEMENTIA AND DERIVATIVES
A COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS
THE USE OF 2,3-TETRAHYDROBENZO[B][1,4]TRIOXIN-5,6-YL]CHROMAN-4-TRIONE AND DERIVATIVES FOR SYMPTOMATIC TREATMENT OF EPILEPSY
A COMPOSITION FOR THE ANTI-INFLAMMATORY AND ANALGESIC TREATMENT
A COMPOSITION FORMED FOR ENURESIS TREATMENT
Contributions communautaires
Discussions
Discussion entre l'organisation et la communauté à propos de ce jeu de données.
Ressources communautaires
Vous avez construit une base de données plus complète que celles présentées ici ? C'est le moment de la partager !
Réutilisations
Vous avez réutilisé ces données et publié un article, une infographie, ou une application ? C'est le moment de vous faire connaître ! Référencez votre travail en quelques clics et augmentez votre visibilité.